Goldman Sachs’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$43M Buy
777,307
+221,756
+40% +$12.3M 0.01% 1223
2025
Q1
$26.9M Sell
555,551
-203,139
-27% -$9.82M ﹤0.01% 1481
2024
Q4
$29.3M Sell
758,690
-63,166
-8% -$2.44M ﹤0.01% 1477
2024
Q3
$37M Buy
821,856
+231,095
+39% +$10.4M 0.01% 1275
2024
Q2
$20.5M Buy
590,761
+65,721
+13% +$2.28M ﹤0.01% 1583
2024
Q1
$15.2M Buy
525,040
+9,820
+2% +$284K ﹤0.01% 1735
2023
Q4
$11.8M Buy
515,220
+48,017
+10% +$1.1M ﹤0.01% 1947
2023
Q3
$7.79M Sell
467,203
-92,007
-16% -$1.53M ﹤0.01% 2158
2023
Q2
$15.4M Buy
559,210
+99,760
+22% +$2.76M ﹤0.01% 1739
2023
Q1
$10.6M Sell
459,450
-157,274
-26% -$3.62M ﹤0.01% 1966
2022
Q4
$6.73M Sell
616,724
-140,355
-19% -$1.53M ﹤0.01% 2415
2022
Q3
$6.38M Buy
757,079
+125,163
+20% +$1.06M ﹤0.01% 2466
2022
Q2
$5M Buy
631,916
+285,557
+82% +$2.26M ﹤0.01% 2648
2022
Q1
$8.2M Buy
346,359
+222,730
+180% +$5.27M ﹤0.01% 2405
2021
Q4
$4.23M Sell
123,629
-299,566
-71% -$10.2M ﹤0.01% 2932
2021
Q3
$7.5M Buy
423,195
+31,252
+8% +$554K ﹤0.01% 2494
2021
Q2
$17.6M Sell
391,943
-22,191
-5% -$996K ﹤0.01% 1833
2021
Q1
$10.7M Sell
414,134
-137,653
-25% -$3.57M ﹤0.01% 2156
2020
Q4
$11.1M Buy
551,787
+329,707
+148% +$6.65M ﹤0.01% 1983
2020
Q3
$4.34M Sell
222,080
-307,968
-58% -$6.02M ﹤0.01% 2476
2020
Q2
$9.36M Buy
530,048
+466,347
+732% +$8.24M ﹤0.01% 1988
2020
Q1
$449K Buy
63,701
+43,562
+216% +$307K ﹤0.01% 3549
2019
Q4
$142K Sell
20,139
-136,822
-87% -$965K ﹤0.01% 4071
2019
Q3
$1.89M Buy
156,961
+132,900
+552% +$1.6M ﹤0.01% 2861
2019
Q2
$291K Sell
24,061
-76,931
-76% -$930K ﹤0.01% 3732
2019
Q1
$1.27M Buy
100,992
+72,993
+261% +$917K ﹤0.01% 3154
2018
Q4
$188K Sell
27,999
-11,370
-29% -$76.3K ﹤0.01% 3755
2018
Q3
$405K Sell
39,369
-43,495
-52% -$447K ﹤0.01% 3532
2018
Q2
$557K Buy
82,864
+51,795
+167% +$348K ﹤0.01% 3475
2018
Q1
$267K Buy
31,069
+1,506
+5% +$12.9K ﹤0.01% 3741
2017
Q4
$615K Buy
+29,563
New +$615K ﹤0.01% 3363
2016
Q4
Sell
-13,340
Closed -$282K 4529
2016
Q3
$282K Buy
+13,340
New +$282K ﹤0.01% 3736